Are major bleeding events from falls more likely in patients on warfarin?

被引：0
|
作者：
Garvin, R [1 ]
Howard, E
机构：
[1] Family Med Spokane, Spokane, WA USA
[2] Harborview Med Ctr, Seattle, WA 98104 USA
来源：
JOURNAL OF FAMILY PRACTICE | 2006年 / 55卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [1] Discrepancies in the identification of major bleeding events in patients taking warfarin
    A. C. Seto
    K. Kenyon
    A. K. Wittkowsky
    Journal of Thrombosis and Thrombolysis, 2008, 25 : 124 - 124
  • [2] Discrepancies in identification of major bleeding events in patients taking warfarin
    Seto, Anna C.
    Kenyon, Kenneth
    Wittkowsky, Ann K.
    PHARMACOTHERAPY, 2008, 28 (09): : 1098 - 1103
  • [3] Discrepancies in the identification of major bleeding events in patients taking warfarin
    Seto, A. C.
    Kenyon, K.
    Wittkowsky, A. K.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 25 (01) : 124 - 124
  • [4] MANAGEMENT AND OUTCOMES OF MAJOR BLEEDING EVENTS IN PATIENTS TAKING DABIGATRAN OR WARFARIN IN CLINICAL PRACTICE
    Smythe, Maureen A.
    Conger, Elizabeth A.
    Hoffman, Janet L.
    Forman, Michael J.
    Koerber, John M.
    Saboo, Shaun A.
    Dezia, Alen L.
    Pillen, Heidi A.
    Qasem, Lina Y.
    Priziola, Jennifer L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E70 - E70
  • [5] Dabigatran proves to be superior to warfarin for reducing major bleeding events in patients with atrial fibrillation
    不详
    FUTURE CARDIOLOGY, 2010, 6 (01) : 8 - 8
  • [6] Management of Major Bleeding Events in Patients Treated With Rivaroxaban Versus Warfarin: Results From the ROCKET AF Trial
    Piccini, Jonathan P.
    Garg, Jyotsna
    Patel, Manesh R.
    Lokhnygina, Yuliya
    Goodman, Shaun G.
    Becker, Richard C.
    Berkowitz, Scott D.
    Breithardt, Gunter
    Hacke, Werner
    Halperin, Jonathan L.
    Hankey, Graeme I.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Singer, Daniel E.
    Califf, Robert M.
    Fox, Keith A.
    CIRCULATION, 2013, 128 (22)
  • [7] Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin
    Burgess, S.
    Crown, N.
    Louzada, M. L.
    Dresser, G.
    Kim, R. B.
    Lazo-Langner, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (09) : 1647 - 1654
  • [8] Warfarin and the risk of major bleeding events in patients with atrial fibrillation: a population-based study
    Azoulay, L.
    Dell'aniello, S.
    Simon, T.
    Renoux, C.
    Suissa, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 671 - 672
  • [9] Warfarin and the risk of major bleeding events in patients with atrial fibrillation: a population-based study
    Azoulay, L.
    Dell'aniello, S.
    Simon, T.
    Renoux, C.
    Suissa, S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 671 - 672
  • [10] Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation
    Boulanger, Luke
    Hauch, Ole
    Friedman, Mark
    Foster, Talia
    Dixon, Deirdre
    Wygant, Gail
    Menzin, Joseph
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1024 - 1029
12345